Comprehensive genomic characterization of HER2-low and HER2-0 breast cancer
2023 · Nature Communications · 58 citations
https://doi.org/10.1038/s41467-023-43324-w
H
Hersh Gupta
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
521
Papers
1.4K
Citations
17
h-index
20
i10-index
Hersh Gupta is an academic researcher from Dana-Farber Cancer Institute. The author has contributed to research in topics: Cancer Genomics and Diagnostics & Lung Cancer Treatments and Mutations & Pancreatic and Hepatic Oncology Research. The author has an h-index of 17, co-authored 443 publications.
ORCID: 0000-0002-5136-6403Papers by this author
worksContemporary prognostic signatures and refined risk stratification of gliomas: An analysis of 4400 tumors
2024 · Neuro-Oncology · 23 citations
https://doi.org/10.1093/neuonc/noae164
Molecular characterization of HER2-negative breast cancers reveals a distinct patient subgroup with 17q12 deletion and heterozygous loss of ERBB2
2025 · ESMO Open · 4 citations
https://doi.org/10.1016/j.esmoop.2024.104111
Supplementary Figure 6 from <i>RAS/RAF</i> Comutation and <i>ERBB2</i> Copy Number Modulates HER2 Heterogeneity and Responsiveness to HER2-directed Therapy in Colorectal Cancer
2024 · 0 citations
https://doi.org/10.1158/1078-0432.25603651.v1
Data from <i>RAS/RAF</i> Comutation and <i>ERBB2</i> Copy Number Modulates HER2 Heterogeneity and Responsiveness to HER2-directed Therapy in Colorectal Cancer
2024 · 0 citations
https://doi.org/10.1158/1078-0432.c.7181326
Supplementary Figure 2 from <i>RAS/RAF</i> Comutation and <i>ERBB2</i> Copy Number Modulates HER2 Heterogeneity and Responsiveness to HER2-directed Therapy in Colorectal Cancer
2024 · 0 citations
https://doi.org/10.1158/1078-0432.25603663.v1
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat